<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-12-22</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-12-3-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Headache Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Acetaminophen, Aspirin, and Caffeine for Migraine</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>03</month>
<year>1998</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>05</month>
<year>2016</year>
</pub-date>
<volume>12</volume>
<issue>3</issue>
<fpage>22</fpage>
<lpage>23</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1998 The Author(s)</copyright-statement>
<copyright-year>1998</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1001/archneur.55.2.210" vol="55" page="210">
<article-title>Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The effectiveness of two tablets of the nonprescription combination of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain was evaluated in 1357 patients (mean age, 36 years) from several centers, enrolled in three double-blind, single-dose, placebo-controlled studies.</p>
</abstract>
<kwd-group>
<kwd>Acute Encephalopathy</kwd>
<kwd>Clustering of Symptoms</kwd>
<kwd>Chronic Encephalopathy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The effectiveness of two tablets of the nonprescription combination of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain was evaluated in 1357 patients (mean age, 36 years) from several centers, enrolled in three double-blind, single-dose, placebo-controlled studies. Pain intensity was significantly reduced within 1 to 6 hours after receiving the combination when compared with the effect of placebo. Within 2 hours, pain was reduced to mild or none in 60% of drug-treated patients compared to 30% of controls; and at 6 hours, 50% were pain free compared to 23% of controls. Associated symptoms, nausea, photophobia, phonophobia, and functional disability, were also significantly improved. Adverse experiences, occurring in 13% of drug-treated compared to 7% of placebo controls, included nausea (5%), nervousness (4%), dizziness (3%), and gastrointestinal symptoms (3%). [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. The nonprescription combination of acetaminophen, aspirin, and caffeine is a safe, cost-effective, treatment for adults with migraine, and this alternative therapy should be indicated also in children and adolescents.</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lipton</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>WF</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>RE</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Saper</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Silberstein</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sheftell</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials</article-title>
<source>Arch Neurol</source>
<year>1998</year>
<month>Feb</month>
<volume>55</volume>
<issue>2</issue>
<fpage>210</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.55.2.210</pub-id>
<pub-id pub-id-type="pmid">9482363</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>